Smart jab can shrink head and neck cancer tumours within six weeks, trial finds

明智的注射能在六周内缩小头颈部癌症肿瘤,试验发现

Head and neck cancer is the sixth most common form of the disease.

Head and neck cancer is the sixth most common form of the disease.

2025-10-19  518  中等
字体大小

Research showed a drug called amivantamab, given as an injection, can shrink tumours in patients with recurrent or metastatic cancer who had tried immunotherapy and chemotherapy. Details were presented at the European Society for Medical Oncology conference in Berlin.

请登录后继续阅读完整文章

还没有账号?立即注册

成为会员后您将享受无限制的阅读体验,并可使用更多功能,了解更多


免责声明:本文来自网络公开资料,仅供学习交流,其观点和倾向不代表本站立场。